Creative Biolabs

Gliadin Nanoparticle Development Service for Targeted Drug Delivery

In the rapidly evolving biopharmaceutical landscape, achieving precision-targeted therapeutic delivery remains a critical bottleneck. Creative Biolabs addresses this challenge with our industry-leading Gliadin Nanoparticle Development Service, a specialized platform engineered to overcome complex biological barriers. By harnessing the unique amphiphilic chemistry of gluten-derived prolamins, we design and optimize robust, biocompatible carriers for a diverse range of payloads. Backed by state-of-the-art interfacial engineering capabilities, Creative Biolabs possesses deep, unmatched expertise in translating raw plant proteins into high-performance, programmable drug delivery vehicles tailored to your research objectives.

Request a Free Scientific Consultation

Technical Foundations of Gliadin-Based Carriers

Decoding the Amphiphilic Chemistry of Gluten-Derived Gliadin

Gliadin is a single-chain polypeptide storage protein with an average molecular weight ranging from 25 to100 kDa and an isoelectric point (pI) of approximately 6.5. Conformationally, gliadin features a unique "amphiphilic" (amphipathic) molecular architecture consisting of a hydrophilic central domain enriched in glutamine and proline residues, flanked by terminal hydrophobic domains containing non-polar amino acids.

Fig. 1 The crystal structure of gliadin.1

Because of this unique primary sequence, gliadin is completely insoluble in pure water but dissolves readily in 70% ethanol solutions. When a hydroethanolic gliadin solution is introduced to an aqueous phase, the sudden shift in solvent polarity triggers spontaneous molecular aggregation and self-assembly. Creative Biolabs leverages this hydrophobic collapse to encapsulate lipophilic therapeutic payloads within the hydrophobic core of the self-assembled nanoparticles, while exposing the hydrophilic domains to the outer aqueous phase to maintain colloid dispersion.

Encapsulation Versatility across Diverse Therapeutic Modalities

Our gliadin-based delivery platform is highly compatible with a broad spectrum of active pharmaceutical ingredients (APIs) and bioactive compounds:


Small-Molecule Hydrophobic Drugs

Protects highly lipophilic and photolabile polyphenols from oxidative and thermal degradation, improving their apparent aqueous solubility and oral bioavailability.

e.g., Resveratrol, Curcumin, Honokiol, Quercetin, Pterostilbene, and Naringin.

Fragile Nucleic Acid Payloads

Utilizes benign, organic-free assembly methods to encapsulate highly unstable genetic cargo, shielding it from ribonuclease (RNase) cleavage while facilitating endosomal escape.

e.g., siRNA, shRNA, mRNA, miRNA, antisense oligonucleotides (ASOs), plasmid DNA, and CRISPR-Cas9 components.

Therapeutic Proteins & Peptides

Encapsulates enzymes, antimicrobial peptides, and hormone mimics under mild physiological conditions to preserve their functional three-dimensional tertiary structures.

Unsaturated Fatty Acids & Volatiles

Protects sensitive lipid double bonds against lipid peroxidation, masking undesirable volatile off-odors and prolonging shelf-life.

e.g., Algal oil, Coix Seed Oil, fish oil, and carvacrol.

Interfacial Tuning & Modification Strategies for Gliadin-Based Carriers

Biopolymers derived from plant storage proteins (such as wheat-derived gliadin and maize-derived zein) possess high hydrophobic density. Consequently, unmodified prolamin nanoparticles are highly prone to irreversible aggregation and precipitation when exposed to physiological ionic environments or pH shifts near their isoelectric points.

Modification of gliadin. (Creative Biolabs Original)Fig. 2 Modification methods of gliadin.

To prevent systemic salt-out, reduce premature clearance by the reticuloendothelial system (RES), and enable receptor-mediated targeted endocytosis, precise chemical, physical, and enzymatic modifications are crucial. These modifications tune the surface zeta potential (zeta-potential) to stable ranges (typically -20 mV to -30 mV), build steric hydration shells, and conjugate tissue-specific ligands.

Modification Category Specific Treatment & Processing Payloads Primary Interfacial & Biological Delivery Benefits
Physical Modification High-Pressure Microfluidization Algal Oil
  • Greatly increases oxidative stability;
  • Limits the generation of lipid hydroperoxides and volatile hexanal
Chemical Modification Maillard-Driven Glycosylation Quercetin
  • Boosts encapsulation efficiency (EE%) by limiting crystallization;
  • Dramatically improves thermal stability and gastrointestinal bioaccessibility.
Enzymatic Modification Controlled Alcalase Hydrolysis Naringin
  • Imparts superior aqueous solubility and hydrophilic dispersibility;
  • Enhances shelf-storage, thermal, and photochemical resilience;
  • Significantly increases in vivo bioavailability
Combined Modification 400 W Ultrasound Pretreatment + Glycosylation Quercetin
  • Synergistically increases loading parameters while reducing scaling expenses;
  • Exhibits superior environmental stability and prevents UV-induced payload degradation;
  • Elevates gastrointestinal bioaccessibility
Combined Modification Chemical Deamidation + Starch Gel Complexation Resveratrol
  • Markedly enhances resveratrol retention under intensive heat and UV-C exposure;
  • Promotes high digestive bioaccessibility.
Polysaccharide Complexation Carboxymethyl Chitosan (CMCS) Electrostatic Coating Curcumin
  • Achieves superior nanoparticle dispersion and high encapsulation parameters;
  • Insulates the colloid from salt-out at high salinity
  • Significantly enhances DPPH/ABTS radical scavenging profiles.
Polysaccharide Complexation Gum Arabic + Chitosan Hydrochloride Coating Resveratrol
  • Imparts outstanding colloid stability and water redispersibility;
  • Elevates oral bioavailability;
  • Demonstrates enhanced Fe3+ reducing power and DPPH scavenging.
Polysaccharide Complexation Tremella Polysaccharide Electrostatic Wrapping Curcumin
  • Improves encapsulation efficiency (EE%);
  • Exhibits excellent physical, photo, and thermal stability upon reconstitution;
  • Dramatically enhances in vitro intestinal permeability.
Polysaccharide Complexation Sodium Alginate Complex Coacervation Curcumin
  • Provides high cargo loading capacity (LC%);
  • Constructs a gel-network barrier to achieve controlled, non-burst release kinetics.
Other Biopolymers Rhamnolipid Biosurfactant Complexation Curcumin
  • Yields an exceptional encapsulation efficiency of 98.70%;
  • Confers top-tier physical dispersibility, photostability, and reconstitution properties.

Tailored Synthesis & Development

Learn More about Gliadin Nanoparticles

Creative Biolabs offers comprehensive contract research organization (CRO) services to guide your custom protein-based delivery project from conceptual feasibility to validated preclinical samples.

Custom Formulation Development & Antisolvent Synthesis

Creative Biolabs provides custom formulation design utilizing advanced, high-throughput liquid-liquid phase separation systems. We systematically map solubility profiles, optimizing parameters such as solute ratios, mixing speed, and solvent-to-antisolvent injection rates to deliver highly reproducible batch-to-batch consistency.

Screening of optimal solvent-antisolvent ratios to establish phase-separation boundaries.

Microfluidic-assisted synthesis for highly monodisperse nanoparticle populations.

Benign, organic-solvent-free self-assembly optimized for sensitive biomolecules and delicate peptide therapeutics.

We modify the outer boundary of the nanoparticles to evade biological barriers and ensure long systemic circulation. By executing precise surface chemistry, we graft steric hydration barriers and target-specific ligands onto the protein shell.

Controlled chemical and electrochemical deamidation to lock the zeta-potential within stable negative ranges (-20 mV to -30  mV).

Covalent conjugation of targeting ligands (e.g., Hyaluronic Acid, cell-penetrating peptides) to enable receptor-mediated intracellular delivery.

Hydrophilic polysaccharide coating (LBL electrostatic deposition) to prevent protein opsonization.

Biocatalytic Cross-Linking & Structural Reinforcement

To prevent premature carrier degradation and cargo burst release in physiological fluid, we offer biocatalytic matrix reinforcement services. This process establishes robust molecular frameworks that resist enzymatic degradation in vivo.

Microbial Transglutaminase (TG) catalyzed cross-linking to establish intermolecular covalent isopeptide bonds.

Calcium-mediated polyelectrolyte complexation to reinforce composite core-shell matrices.

Fine-tuning of digestion profiles to ensure programmed release in simulated gastric (SGF) versus intestinal (SIF) fluids.

Every custom formulation program is subjected to rigorous quality control and physical validation. We provide our clients with a detailed, publication-ready data dossier to support academic publications or preclinical regulatory filings.

Particle size, polydispersity index (PDI), and Zeta potential analysis using Dynamic Light Scattering (DLS).

Morphological characterization via Field Emission Scanning Electron Microscopy (FE-SEM) and Transmission Electron Microscopy (TEM).

Precision determination of encapsulation efficiency (EE%) and loading capacity (LC%) using high-performance liquid chromatography (HPLC) and spectrophotometric assays:

Precision Gliadin Nanotechnology for Targeted Drug Delivery →

Workflow

Workflow of Creative Biolabs. (Creative Biolabs Original)

Cross-Disciplinary Delivery Applications

Why Choose Creative Biolabs?

Request a Quote

Creative Biolabs is a pioneer in the design, optimization, and synthesis of plant-protein-based nanocarriers, offering custom-engineered solutions for biotechnology, pharmaceuticals, food science, and active packaging. Our specialized Gliadin Nanoparticle Development Service provides leading-edge formulation expertise, helping you overcome poor solubility, systemic instability, and biological barriers. Whether your program focuses on complex hydrophobic small molecules, fragile nucleic acids, or industrial Pickering emulsions, our elite team of physical chemists and formulation scientists is ready to deliver a customized, high-performance targeted drug delivery solution tailored to your exact specifications.

Proprietary Interfacial Chemistry

Our advanced electrochemical deamidation technology shifts the carrier's zeta potential to highly stable negative ranges, achieving superior self-dispersion without using synthetic, toxic surfactants.

Outstanding Encapsulation Metrics

We routinely achieve encapsulation efficiencies EE%) exceeding 90% for highly challenging, lipophilic compounds.

Synergistic Shielding Engineering

We utilize highly purified natural polysaccharides (such as carboxymethyl chitosan and hyaluronic acid) to form resilient "nanocage" structures, providing exceptional stability against physiological salinity.

Preclinical Scientific Rigor

Every custom formulation program is fully validated using high-resolution TEM/SEM, and DLS.

Related Services & Products

Related Services

FAQs

Why choose gliadin-based delivery systems for hydrophobic payloads?

Gliadin's hydrophobic core acts as a natural micellar solubilizer, suppressing drug crystallization and yielding stable aqueous dispersions.

How does gliadin improve drug bioavailability?

Its surface glutamine residues form strong hydrogen bonds with mucosal glycoproteins, prolonging mucosal residence time to facilitate continuous passive absorption.

How do you address the potential immunogenicity of gliadin?

We apply proprietary enzymatic and chemical deamidation to alter antigenic epitopes, ensuring a safe, biocompatible profile in research models.

What is the typical encapsulation efficiency (EE%) for nucleic acids in your gliadin platform?

Our benign, pH-driven self-assembly routinely achieves nucleic acid encapsulation efficiencies (EE%) of 80% to 95%.

How does polysaccharide complexation prevent nanoparticle aggregation?

Polysaccharide coatings introduce strong electrostatic and steric repulsion, maintaining colloidal stability under physiological ionic strengths (NaCl > 100 mg/L).

Reference

  1. Aljabali, Alaa AA, et al. "Protein-based nanomaterials: a new tool for targeted drug delivery." Therapeutic delivery 13.6 (2022): 321-338. https://doi.org/10.4155/tde-2021-0091. Distributed under Open Access license CC BY 4.0, without modification.
Our services are For Research Use Only. We do not provide services to individuals.
Online Inquiry

Customer Review

Creatibe Biolabs' custom LNP was the only solution that successfully delivered our CRISPR-Cas9 payload across the blood-brain barrier with high efficiency and low toxicity.”

Dr. Evelyn Reed

Postdoctoral Researcher, Leading University

Our siRNA candidate was failing due to off-target toxicity, but Creatibe Biolabs' team rapidly redesigned our LNP using their modular platform, rescuing our preclinical program.”

Ben Carter

Project Manager

Achieving cytosolic delivery of our protein degrader with Creatibe Biolabs' exosome platform was the key to unlocking our candidate's full therapeutic potential.”

Dr. Kenji Tanaka

Principal Scientist, Large Pharma Corp

Our oncology drug's efficacy was limited by poor tumor accumulation. Creatibe Biolabs' peptide-conjugated liposomes provided the precise targeting we needed, dramatically increasing the drug's therapeutic index.”

Dr. Clara Schmidt

Senior Scientist, Oncology Innovations Inc.

We required a delivery system that would only release its payload in the tumor's acidic microenvironment. Creatibe Biolabs' pH-responsive liposomes performed flawlessly, minimizing systemic exposure.”

David Chen

Formulation Scientist

Outstanding expertise in antibody engineering.The team's attention to detail and innovative approaches have sianificantly accelerated our development timeline.

Sarah L.

Senior Research Scientist

Contact us for more information Get free consultations
ad